BCAT2 and lung cancer: In non–small-cell lung cancer (NSCLC), BCAAs are used as nitrogen sources, and the dysfunction of the enzymes branched-chain amino acid transaminase (BCAT) 1 and BCAT2, which are responsible for BCAA usage, impairs NSCLC tumor formation [38].